Geneva, March 31 -- International Clinical Trials Registry received information related to the study (ACTRN12626000360314) titled 'A multicentre pilot feasibility randomised controlled trial of multidrug-resistant organism-guided antibiotic prophylaxis and a fixed five-day duration of antifungal prophylaxis in liver transplant recipients' on March 23.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Other
Type of endpoint: Safety/efficacy
Primary Sponsor: Austin Health
Condition:
liver transplant
multidrug-resistant organism infection
invasive fungal infection
liver transplant
multidrug-resistant organism infection
invasive fungal infe...